摘要
肝是控制血糖和脂质代谢的关键。肝脏中脂肪过多的积累使肝功能紊乱,并导致脂肪肝的形成。在没有大量饮酒的患者中,非酒精性脂肪性肝(NAFLD)是脂肪肝的常见类型。多种因素和细胞类型导致了NAFLD的发生和发展。饮食中含有提供能量的营养物质以及具有调节作用的微量元素。作为人体必需微量元素,维生素A(VA)在肝脏葡萄糖和脂质代谢等生理功能中起着关键作用。VA主要储存在静止期肝星状细胞(HSC)中。肝细胞促进VA代谢从而改变代谢葡萄糖和脂质的代谢。有趣的是,激活的造血干细胞中VA含量降低并能导致NAFLD的进展。已经有大量研究VA代谢和脂肪肝发展之间联系的报道。本文对现有文献总结,探讨发生在局部肝细胞和肝星状细胞之间、NAFLD发展过程中肝细胞内的VA代谢变化。研究表明,肝星状细胞和肝细胞的相互影响因素可以导致NAFLD的发展。此外,本文讨论了VA过量代谢增加脂肪合成、促进肝细胞脂肪累积的可能机制。这为研究VA代谢在NAFLD发展中的作用提供了一个参考方向。
关键词: 非酒精性脂肪性肝病,维生素A,维甲类物质,肝星状细胞,肝细胞,胰岛素。
图形摘要
Current Drug Targets
Title:The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease
Volume: 16 Issue: 12
Author(s): Guoxun Chen
Affiliation:
关键词: 非酒精性脂肪性肝病,维生素A,维甲类物质,肝星状细胞,肝细胞,胰岛素。
摘要: The liver is essential for the control of glucose and lipid metabolism. Excessive accumulation of fat in the liver disturbs its function and leads to the development of fatty liver diseases. The nonalcoholic fatty liver disease (NAFLD) is a common type of fatty liver disease found in patients who have not consumed significant amount of alcohol. Multiple factors and cell types contribute to the development and progression of NAFLD. Diets contain macronutrients with energy and micronutrients with regulatory roles. As an essential micronutrient, vitamin A (VA), plays critical roles in various physiological functions including the regulation of glucose and lipid homeostasis in the liver. The body’s VA is mainly stored in quiescent hepatic stellate cells (HSCs) in the liver. Hepatocytes actively metabolize VA, and change glucose and lipid metabolism in response to VA metabolites. Interestingly, the activated HSCs lose their VA content and contribute to the NAFLD progression. Significant number of studies have been conducted to investigate the link between VA metabolism and NAFLD development. This review is to summarize current literatures that discuss the changes of VA metabolism occurring locally between hepatocytes and HSCs, and intracellularly in hepatocytes during the course of NAFLD development. It appears that factors derived from HSCs and hepatocytes mutually affect each other, which contributes to NAFLD development. Additionally, this review discusses the potential mechanism by which excessive VA metabolism increases lipogenesis and contributes to fat accumulation in hepatocytes. It offers potential future directions for the study of the role of VA metabolism in the NAFLD development.
Export Options
About this article
Cite this article as:
Guoxun Chen , The link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease, Current Drug Targets 2015; 16 (12) . https://dx.doi.org/10.2174/1389450116666150325231015
DOI https://dx.doi.org/10.2174/1389450116666150325231015 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Status and Ongoing Development of Reversing Agents for Novel Oral Anticoagulants (NOACs)
Recent Patents on Cardiovascular Drug Discovery Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?
Current Pharmaceutical Biotechnology The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology New Insights into Binding Interfaces of Coagulation Factors V and VIII and their Homologues - Lessons from High Resolution Crystal Structures
Current Protein & Peptide Science Nitric Oxide-Dependent Neovascularization Role in the Lower Extremity Disease
Current Pharmaceutical Design Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Hybrid Organic-Inorganic Scaffolding Biomaterials for Regenerative Therapies
Current Organic Chemistry Chitosan Applications on Pharmaceutical Sciences: A Review
Drug Delivery Letters Recombinant Factor VIIA, its Clinical Properties, and the Tissue Factor Pathway of Coagulation
Mini-Reviews in Medicinal Chemistry Traumatic Brain Injury: Central and Peripheral Role of α7 Nicotinic Acetylcholine Receptors
Current Drug Targets Molecularly Imprinted Sol-Gel Materials for Medical Applications
Current Topics in Medicinal Chemistry Fishing Anti-Inflammatories from Known Drugs: In Silico Repurposing, Design, Synthesis and Biological Evaluation of Bisacodyl Analogues
Current Topics in Medicinal Chemistry The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery
Current Vascular Pharmacology Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery The Role of Platelets in Athero-Thrombotic Events
Current Pharmaceutical Design Discovery and Preliminary SAR of 5-Arylidene-2,2-Dimethyl-1,3-Dioxane- 4,6-Diones as Platelet Aggregation Inhibitors
Combinatorial Chemistry & High Throughput Screening A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
Current Traditional Medicine Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures
Current Pharmaceutical Design Natural Products as Promising Drug Candidates for the Treatment of Alzheimer’s Disease: Molecular Mechanism Aspect
Current Neuropharmacology Drugs in Pediatric Ischemic Stroke
Current Drug Targets